Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures.
The deal, billed as a merger of equals, comes amid a surge in demand for copper, a crucial component in technology, from data centers to electric vehicles.
The oil giant said Tuesday that it was acquiring assets from a Chicago company as it looks to start producing graphite, a key battery ingredient, by the end of the decade.